Hints and tips:
Showing results for Hilmes v. Biotech Xray, Inc.
...Rivals AstraZeneca, Johnson & Johnson, Russia’s Sputnik V and new entrants such as Novavax make up the remainder of the market, which is forecast to double in value to $124bn next year....
...Mr Kulkarni said the sector would become more like “Apple v Samsung”, where biotechs competed on adding generation after generation of features....
...Thanks to a series of court rulings since the mid-2000s, such as eBay v MercExchange in 2007, Mayo Collaborative Services v Prometheus Laboratories in 2012 and Alice Corp v CLS Bank in 2014, and the subsequent...
...The group posted net income of $240m for the three months to June 30, compared with a $162m loss a year earlier because of costs related to its purchase of US biotech Baxalta last year....
...It bought the US biotech group Seragon Pharmaceuticals for a cost of up to $1.7bn in July, and the US gene-sequencing group Genia for up to $350m in June....
...“I would probably go into biotech, not computing,” he said. “I think you want to go into a field where the innovation rate is very high. The computer industry is maturing....
...The case, KSR v Teleflex, involved an adjustable accelerator pedal....
...The US government on Wednesday intervened in the case on the side of MedImmune, a biotechnology company that licensed a drug patent from Genentech, another biotech firm....
...Biotech companies that send “master cells” for copying abroad could also be vulnerable....
International Edition